Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer

NCT06042998 · The Affiliated Hospital of Qingdao University · Updated 21 Sept 2023

What is being tested
Robotic radical gastrectomy
For
Gastric Cancer Stage II; Gastric Cancer Stage III
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 75 years. About 588 people. The full rules are on the registry page.
Where
China
When
Starts or started 7 July 2023, ends 30 Dec 2027. Registered 21 Sept 2023.
Results
None posted yet.

In the researchers' words

To evaluate the clinical efficacy of robot radical Gastrectomy and laparoscopic radical Gastrectomy, patients with gastric adenocarcinoma (cT2N+M0 or cT3-4a/N+M0, phase II and III) undergoing neoadjuvant treatment were selected as subjects.
ClinicalTrials.gov, NCT06042998

Sites

  • Department of Gastrointestinal Surgery, Qingdao University Affiliated HospitalQingdao, Shandong, China